(2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane

C50H86N8O11 — CID 160514730

IUPAC(2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane
SMILESC.Cn1ccnc1CN(CCCC[C@H](CC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)C(=O)O)Cc1nccn1C
InChIInChI=1S/C49H82N8O11.CH4/c1-47(2,3)66-42(60)25-24-38(45(64)68-49(7,8)9)54-46(65)53-37(44(63)67-48(4,5)6)22-16-18-26-52-41(59)23-15-13-12-14-21-36(58)32-35(43(61)62)20-17-19-29-57(33-39-50-27-30-55(39)10)34-40-51-28-31-56(40)11;/h27-28,30-31,35,37-38H,12-26,29,32-34H2,1-11H3,(H,52,59)(H,61,62)(H2,53,54,65);1H4/t35-,37+,38+;/m1./s1
InChIKeyQTMQREZYWBWGKS-AYKVKHNISA-N
MW975.28 g/mol
LogP7.09
Rot. Bonds31

About (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane

(2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane (PubChem CID 160514730) has the molecular formula C50H86N8O11 and a molecular weight of 975.28 g/mol. Its IUPAC name is (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane.

Molecular Properties

Compound Name(2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane
PubChem CID160514730
Molecular FormulaC50H86N8O11
Molecular Weight975.28 g/mol
Exact Mass974.64
IUPAC Name(2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane
SMILESC.Cn1ccnc1CN(CCCC[C@H](CC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)C(=O)O)Cc1nccn1C
InChIInChI=1S/C49H82N8O11.CH4/c1-47(2,3)66-42(60)25-24-38(45(64)68-49(7,8)9)54-46(65)53-37(44(63)67-48(4,5)6)22-16-18-26-52-41(59)23-15-13-12-14-21-36(58)32-35(43(61)62)20-17-19-29-57(33-39-50-27-30-55(39)10)34-40-51-28-31-56(40)11;/h27-28,30-31,35,37-38H,12-26,29,32-34H2,1-11H3,(H,52,59)(H,61,62)(H2,53,54,65);1H4/t35-,37+,38+;/m1./s1
InChIKeyQTMQREZYWBWGKS-AYKVKHNISA-N
XLogP7.09
TPSA242.38 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds31
Heavy Atoms69
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500975.28
LogP ≤ 57.09
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane?
The IUPAC name of (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane (CID 160514730) is (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane.
What is the SMILES notation for (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane?
The canonical SMILES for (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane is C.Cn1ccnc1CN(CCCC[C@H](CC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)OC(C)(C)C)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)C(=O)O)Cc1nccn1C.
What is the InChIKey of (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane?
The InChIKey is QTMQREZYWBWGKS-AYKVKHNISA-N. The full InChI is InChI=1S/C49H82N8O11.CH4/c1-47(2,3)66-42(60)25-24-38(45(64)68-49(7,8)9)54-46(65)53-37(44(63)67-48(4,5)6)22-16-18-26-52-41(59)23-15-13-12-14-21-36(58)32-35(43(61)62)20-17-19-29-57(33-39-50-27-30-55(39)10)34-40-51-28-31-56(40)11;/h27-28,30-31,35,37-38H,12-26,29,32-34H2,1-11H3,(H,52,59)(H,61,62)(H2,53,54,65);1H4/t35-,37+,38+;/m1./s1.
What are the key properties of (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane?
(2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane has a molecular weight of 975.28 g/mol, XLogP of 7.09, 31 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[4-[bis[(1-methylimidazol-2-yl)methyl]amino]butyl]-11-[[(5S)-5-[[(2S)-1,5-bis[(2-methylpropan-2-yl)oxy]-1,5-dioxopentan-2-yl]carbamoylamino]-6-[(2-methylpropan-2-yl)oxy]-6-oxohexyl]amino]-4,11-dioxoundecanoic acid;methane is sourced from PubChem (CID 160514730), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).